These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Sharma SK; Sharma A; Kadhiravan T; Tharyan P Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis. Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771 [TBL] [Abstract][Full Text] [Related]
7. Tuberculosis in people with HIV. Payne B; Bellamy R BMJ Clin Evid; 2007 Jun; 2007():. PubMed ID: 19454087 [TBL] [Abstract][Full Text] [Related]
8. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Sharma SK; Sharma A; Kadhiravan T; Tharyan P Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581 [TBL] [Abstract][Full Text] [Related]
9. Six-month therapy for abdominal tuberculosis. Jullien S; Jain S; Ryan H; Ahuja V Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012163. PubMed ID: 27801499 [TBL] [Abstract][Full Text] [Related]
10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
12. HIV: primary and secondary prophylaxis for opportunistic infections. Aberg J; Powderly W BMJ Clin Evid; 2010 Jun; 2010():. PubMed ID: 21418688 [TBL] [Abstract][Full Text] [Related]
13. Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. Tweed CD; Dawson R; Burger DA; Conradie A; Crook AM; Mendel CM; Conradie F; Diacon AH; Ntinginya NE; Everitt DE; Haraka F; Li M; van Niekerk CH; Okwera A; Rassool MS; Reither K; Sebe MA; Staples S; Variava E; Spigelman M Lancet Respir Med; 2019 Dec; 7(12):1048-1058. PubMed ID: 31732485 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]. Wada M Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781 [TBL] [Abstract][Full Text] [Related]